Delivery Order SPE2DB22D1017-SPE2DB24FG5BB

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,991.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ARANESP 40 MCG/0.4 ML SYRINGE 0.4ML, a specialty medication, with a completion date of December 9, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not part of a set-aside program. AmerisourceBergen Drug Corp, a for-profit organization, has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,749.18 firm fixed-price delivery order contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a medical product, to support federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,941.76 delivery order contract is for the supply of ARANESP 40 MCG/0.4 ML SYRINGE 0.4ML, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 22, 2024. AmerisourceBergen, as the prime contractor, will be responsible for delivering the requested...
This federal contract award, valued at $1,657.80, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ARANESP 25 MCG/0.42 ML SYRING 0.42ML, a pharmaceutical product, with a completion date of September 17, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,845.98, is a Firm Fixed Price Delivery Order for the supply of ARANESP 200 MCG/0.4 ML SYRINGE 0.4ML, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,948.90, is a Firm Fixed Price Delivery Order for the supply of ARANESP 500 MCG/1 ML SYRINGEML medication. The contract has an ultimate completion date of December 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,637.59 firm fixed-price delivery order is for the supply of ARANESP 300 MCG/0.6 ML SYRINGE 0.6ML, a pharmaceutical product used to treat certain medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The...
This federal contract award, valued at $4,627.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a specialty pharmaceutical product. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ARANESP 500 MCG/1 ML SYRINGEML, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,692.69 firm fixed price delivery order is a part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,376.14, is for the delivery of ARANESP 60 MCG/0.3 ML SYRINGE 0.3ML, a specialty medication. This is a Firm Fixed Price Delivery Order contract with a completion date of January 22, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG5BB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ARANESP 40 MCG/0.4 ML SYRINGE 0.4ML. The award, valued at $1,313.92, is a Delivery Order under a pre-existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 13, 2024.

Generated 12/12/24, 10:02 AM